Nevertheless, other researches in colorectal, gastric, gallbladder, prostate and triple negative breast cancer, proved CD73 was an unfavorable prognostic marker [2, 5, 24, 25]. This evidence concerns the gene NT5E and triple-negative breast carcinoma.